|
Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection Clinical research trials and Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection. Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection  Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection
Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection
For Condition: Chagas Disease,Malaria,Parasitic Disease,Trypanosomiasis
Status: Recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: The purpose of this study is to evaluate, treat and follow patients with parasitic infections. People with a known or suspected parasitic infection who are at least 1 year old may be enrolled. This study does not involve any experimental treatments. Participants will have a physical examination and laboratory tests on blood, stool, or urine. Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds) of body weight from children, in any 6-week period. Other tests may include x-rays, electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample), depending on the individual's condition. Patients may be offered treatment or may be referred to another study that is more appropriate for the problem. Any treatment provided in this study will be according to standard medical practice for the patient's specific medical problem. Patients' responses to treatment will be evaluated at regularly scheduled clinic visits. The length of time between visits and the total duration of the study for a given individual will be determined by the study doctor, based on that person's medical condition.
Details: This study is designed as a prospective study to evaluate and treat patients with parasitic infection. Up to 300 patients with known or suspected parasitic infection will be enrolled and will be evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit will include a medical history, physical examination, routine laboratory tests and specialized diagnostic procedures for possible parasitic infections. Treatment plans will be individualized for each patient's particular condition, and the number and length of additional visits and diagnostic evaluations will vary accordingly. Specific treatment regimens will be in accordance with standard medical practice.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Age1 or over. Ability to give written informed consent (for adults) and parental consent (for those under 18). Clinical evidence suggestive of a parasitic infection.
Total Enrollment: 300
Location and Contact Information:
National Institute of Allergy and Infectious Diseases (NIAID) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 970096; 97-I-0096
Study Start Date: March 19, 1997
Record last reviewed: February 25, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001645
Other Chagas Disease Studies:
1. Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection
2. Activation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia
3. Parasitic Infections of the Gastrointestinal Tract
Related Studies:
Other Chagas Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection
|
|
|
|
|
|
|
|
